Skip to menu Skip to content Skip to footer
Professor Craig Munns
Professor

Craig Munns

Email: 
Phone: 
+61 7 3069 7362

Overview

Background

Professor Craig Munns is the Mayne Professor of Paediatrics and Director of the Child Health Research Centre, The University of Queensland. Professor Munns is also a Senior Medical Officer in Paediatric Endocrinology and Diabetes at Queensland Children’s Hospital. He graduated from The University of Queensland, before training in paediatrics and endocrinology at The Royal Children’s Hospital, Brisbane. Professor Munns completed his PhD in paediatric growth disorders through UQ. He then undertook a post-doctoral fellowship in paediatric genetic bone disorders at The Shriners Hospital for Children, Montreal, Canada. From 2004 to 2021, Prof Munns was Senior Staff Specialist in Genetic and Metabolic Bone Disorders and Paediatric Endocrinologist at The Children’s Hospital at Westmead, Sydney. He also undertook roles as Clinical Program Director, Division of Diagnostic Services and Clinical Trials Lead at Kids Research. As Clinical Trials Lead his focus was on developing a research-intensive health system and introducing advanced therapeutics.

Professor Munns is an international expert in paediatric musculoskeletal disorders. His primary clinical and research interests are in diagnosis and management of primary and secondary bone disorders, including osteogenesis imperfecta, hypophosphataemic rickets, disuse osteoporosis and nutritional rickets. He has undertaken a wide range of investigator initiated and sponsored clinical trials, authored international consensus documents and has supervised numerous PhD and Masters students. Prof Munns is actively involved in national and international scientific societies. He was treasurer of Asia Pacific Paediatric Endocrine Society, is the inaugural treasurer of the International Society of Children’s Bone Health and has chaired the program organising committees Australasian Paediatric Endocrine Group, Australian and New Zealand Bone and Mineral Society and International Conference of Children’s Bone Health.

Availability

Professor Craig Munns is:
Available for supervision
Media expert

Qualifications

  • Bachelor of Faculty of Medicine, The University of Queensland
  • Doctor of Philosophy of Paediatrics and Reproductive Medicine, The University of Queensland
  • Fellow, Royal Australasian College of Physicians, Royal Australasian College of Physicians

Research interests

  • Paediatric Musculoskeletal Disorders

    Primary and secondary osteoporosis; Genetic rickets (X-linked hypophosphataemia); Nutritional rickets; Focal bone tumours (Giant cell granuloma, Aneurismal bone cysts); Early detection of disease; Bone density assessment

  • Clinical Trials

    Investigator initiated; Pharmaceutical sponsored; Gene therapy

Research impacts

Professor Munns has developed international consensus guidelines on the prevention and treatment of nutritional rickets. These guidelines have the potential to irradicate this potentially devastating, fully preventable childhood disorder. He has also developed numerous clinical guidelines for the management of paediatric bone disorders such as osteoporosis, X-linked hypophosphataemia, giant cell granuloma and aneurismal bone cysts.

Works

Search Professor Craig Munns’s works on UQ eSpace

190 works between 2000 and 2025

181 - 190 of 190 works

2004

Journal Article

Three children with lower limb fractures and a mineralization defect: A novel bone fragility disorder?

Munns, Craig F.J., Rauch, Frank, Travers, Rose and Glorieux, Francis H. (2004). Three children with lower limb fractures and a mineralization defect: A novel bone fragility disorder?. Bone, 35 (5), 1023-1028. doi: 10.1016/j.bone.2004.08.004

Three children with lower limb fractures and a mineralization defect: A novel bone fragility disorder?

2004

Journal Article

Maternal and fetal outcome after long-term pamidronate treatment before conception: A report of two cases

Munns, Craig F.J., Rauch, Frank, Ward, Leanne and Glorieux, Francis H. (2004). Maternal and fetal outcome after long-term pamidronate treatment before conception: A report of two cases. Journal of Bone and Mineral Research, 19 (10), 1742-1745. doi: 10.1359/JBMR.040711

Maternal and fetal outcome after long-term pamidronate treatment before conception: A report of two cases

2004

Journal Article

Clinical vignette - Sclerotic metaphyseal lines in a child treated with pamidronate: Histomorphometric analysis

Rauch, Frank, Travers, Rose, Munns, Craig and Glorieux, Francis H. (2004). Clinical vignette - Sclerotic metaphyseal lines in a child treated with pamidronate: Histomorphometric analysis. Journal of Bone and Mineral Research, 19 (7), 1191-1193. doi: 10.1359/JBMR.040303

Clinical vignette - Sclerotic metaphyseal lines in a child treated with pamidronate: Histomorphometric analysis

2004

Journal Article

Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta

Munns, Craig F., Rauch, Frank, Mier, Richard J. and Glorieux, Francis H. (2004). Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta. Bone, 35 (1), 231-234. doi: 10.1016/j.bone.2004.03.008

Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta

2003

Journal Article

Familial growth and skeletal features associated with SHOX haploinsufficiency

Munns, C. F. J., Glass, I. A., Flanagan, S., Hayes, M., Williams, B., Berry, M., Vickers, D., O'Rourke, P., Rao, E., Rappold, G. A., Hyland, V. J. and Batch, J. A. (2003). Familial growth and skeletal features associated with SHOX haploinsufficiency. Journal of Pediatric Endocrinology and Metabolism, 16 (7), 987-996. doi: 10.1515/JPEM.2003.16.7.987

Familial growth and skeletal features associated with SHOX haploinsufficiency

2003

Journal Article

Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone

Plotkin, Horacio, Rauch, Frank, Zeitlin, Leonid, Munns, Craig, Travers, Rose and Glorieux, Francis H. (2003). Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone. Journal of Clinical Endocrinology and Metabolism, 88 (10), 4569-4575. doi: 10.1210/jc.2003-030050

Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone

2003

Journal Article

Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency

Munns, C. F. J., Berry, M., Vickers, D., Rappold, G. A., Hyland, V. J., Glass, I. A. and Batch, J. A. (2003). Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency. Journal of Pediatric Endocrinology and Metabolism, 16 (7), 997-1004. doi: 10.1515/JPEM.2003.16.7.997

Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency

2002

Journal Article

Prevalence of mutations in the short stature homeobox containing gene (SHOX) in Madelung deformity of childhood [4]

Flanagan, S. F., Munns, C. F.J., Hayes, M., Williams, B., Berry, M., Vickers, D., Rao, E., Rappold, G. A., Batch, J. A., Hyland, V. J. and Glass, I. A. (2002). Prevalence of mutations in the short stature homeobox containing gene (SHOX) in Madelung deformity of childhood [4]. Journal of Medical Genetics, 39 (10), 758-763.

Prevalence of mutations in the short stature homeobox containing gene (SHOX) in Madelung deformity of childhood [4]

2001

Journal Article

Height discordance in monozygotic females is not attributable to discordant inactivation of X-linked stature determining genes

Healey, S. C., Kirk, K. M., Hyland, V. J., Munns, C., Henders, A. K., Batch, J. A., Heath, A. C., Martin, N. G. and Glass, I. A. (2001). Height discordance in monozygotic females is not attributable to discordant inactivation of X-linked stature determining genes. Twin Research, 4 (1), 19-24. doi: 10.1375/twin.4.1.19

Height discordance in monozygotic females is not attributable to discordant inactivation of X-linked stature determining genes

2000

Journal Article

Hepatic glycogenosis: Reversible hepatomegaly in type 1 diabetes

Munns, C. F. J., McCrossin, R. B., Thomsett, M. J. and Batch, J. (2000). Hepatic glycogenosis: Reversible hepatomegaly in type 1 diabetes. Journal of Paediatrics and Child Health, 36 (5), 449-452. doi: 10.1046/j.1440-1754.2000.00547.x

Hepatic glycogenosis: Reversible hepatomegaly in type 1 diabetes

Funding

Current funding

  • 2024 - 2026
    The 360-Kids community Network to support children with neurodevelopment challenges (HERA 2.0 partnership)
    Health and Wellbeing Queensland
    Open grant
  • 2024 - 2028
    Klinefelter Syndrome Registry
    William Ivers Memorial Fund
    Open grant
  • 2023 - 2027
    Australian Cerebral Palsy Musculoskeletal Health Network
    NHMRC MRFF EPCDR - Chronic Musculoskeletal Conditions in Children and Adolescents
    Open grant
  • 2022 - 2026
    Children with Lower Limb Pain (CLLiP): Working with families, community and health care provider's to improve outcomes (MRFF Chronic Musculoskeletal administered by Monash University)
    Monash University
    Open grant

Supervision

Availability

Professor Craig Munns is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Tele-Dialysis in community settings: Is it feasible, safe and effective?

    Principal Advisor

  • Doctor Philosophy

    Urinary stem cells for diagnosis and characterisation of primary bone disorders

    Principal Advisor

    Other advisors: Professor Di Yu

  • Doctor Philosophy

    Food Allergy Diagnosis and Management in Late Adolescence

    Associate Advisor

    Other advisors: Associate Professor Jennifer Koplin

Media

Enquiries

Contact Professor Craig Munns directly for media enquiries about:

  • Paediatric Bone
  • Rickets
  • Vitamin D

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au